195 related articles for article (PubMed ID: 21174589)
1. Alternations of maternal and cord plasma hemostasis in preeclampsia before and after delivery.
Xiong Y; Zhou SF; Zhou R; Yang D; Xu ZF; Lou YT; Guo QS; Hu R; Peng T; Ma D; Li XT
Hypertens Pregnancy; 2011; 30(3):347-58. PubMed ID: 21174589
[TBL] [Abstract][Full Text] [Related]
2. [Changing characteristic of blood coagulation factors and their correlation with blood coagulation status in different hepatic diseases].
Chen J; Duan ZP; Bai L; Zhao J; Ding M; Tong XY; Cong YL
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):206-10. PubMed ID: 22475141
[TBL] [Abstract][Full Text] [Related]
3. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.
Erez O; Gotsch F; Mazaki-Tovi S; Vaisbuch E; Kusanovic JP; Kim CJ; Chaiworapongsa T; Hoppensteadt D; Fareed J; Than NG; Nhan-Chang CL; Yeo L; Pacora P; Mazor M; Hassan SS; Mittal P; Romero R
J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615
[TBL] [Abstract][Full Text] [Related]
4. Hemostatic abnormalities in patients with severe preeclampsia.
Heilmann L; Rath W; Pollow K
Clin Appl Thromb Hemost; 2007 Jul; 13(3):285-91. PubMed ID: 17636190
[TBL] [Abstract][Full Text] [Related]
5. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies.
Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patricio B; Quintanilha A; Santos-Silva A
Thromb Res; 2008; 123(2):219-24. PubMed ID: 18384840
[TBL] [Abstract][Full Text] [Related]
6. [Changes of relative variables about prethrombosis state and its clinical significance in patients with pregnancy induced hypertension].
Liu BY; Zhong M; Yu YH; Zheng L; Wang Q; Guo WL
Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):85-8. PubMed ID: 12783694
[TBL] [Abstract][Full Text] [Related]
7. Maternal and cord blood hemostasis at delivery.
Schneider DM; von Tempelhoff GF; Herrle B; Heilmann L
J Perinat Med; 1997; 25(1):55-61. PubMed ID: 9085204
[TBL] [Abstract][Full Text] [Related]
8. Haemostatic factors in women with history of preeclampsia.
Portelinha A; Cerdeira AS; Belo L; Braga J; Tejera E; Pinto A; Pinto F; Areias MJ; Patrício B; Rebelo I
Thromb Res; 2009 May; 124(1):52-6. PubMed ID: 19049844
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of the hemostasis parameters in the development of preeclampsia.
Ho CH; Yang ZL
Thromb Haemost; 1992 Feb; 67(2):214-8. PubMed ID: 1621241
[TBL] [Abstract][Full Text] [Related]
10. Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor.
Godoi LC; Gomes KB; Alpoim PN; Carvalho Md; Lwaleed BA; Sant'Ana Dusse LM
J Thromb Thrombolysis; 2012 Jul; 34(1):1-6. PubMed ID: 22461171
[TBL] [Abstract][Full Text] [Related]
11. [Hemostatic system parameters of placental extracts in normal pregnancy and severe preeclampsia].
López-Ramírez Y; Carvajal Z; Arocha-Piñango CL
Invest Clin; 2006 Sep; 47(3):233-40. PubMed ID: 17672283
[TBL] [Abstract][Full Text] [Related]
12. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
[TBL] [Abstract][Full Text] [Related]
13. Severe preeclampsia: are hemostatic and inflammatory parameters associated?
Pinheiro MB; Carvalho MG; Martins-Filho OA; Freitas LG; Godoi LC; Alpoim PN; Gomes KB; Dusse LM
Clin Chim Acta; 2014 Jan; 427():65-70. PubMed ID: 24121033
[TBL] [Abstract][Full Text] [Related]
14. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia.
Schjetlein R; Abdelnoor M; Haugen G; Husby H; Sandset PM; Wisløff F
Acta Obstet Gynecol Scand; 1999 Mar; 78(3):191-7. PubMed ID: 10078579
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor and tissue factor pathway inhibitor in women with a past history of preeclampsia: implication for a hypercoagulable state postpregnancy.
Lwaleed BA; Breish MO; Birch BR; Chowdhary AP; Saad RA; Perigo O; Kazmi RS; Dusse LM; Cooper AJ
Blood Coagul Fibrinolysis; 2014 Oct; 25(7):671-4. PubMed ID: 24806321
[TBL] [Abstract][Full Text] [Related]
16. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
Nadar SK; Al Yemeni E; Blann AD; Lip GY
Thromb Res; 2004; 113(2):123-8. PubMed ID: 15115667
[TBL] [Abstract][Full Text] [Related]
17. [Pre- and postpartum hemostatic characteristics in pregnancy-related hypertension and pre-eclampsia in comparison with normotensive pregnancies].
Hofmann M; Casper F; Prellwitz W; Brockerhoff P
Z Geburtshilfe Neonatol; 1996; 200(3):104-8. PubMed ID: 8963881
[TBL] [Abstract][Full Text] [Related]
18. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.
Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL
Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515
[TBL] [Abstract][Full Text] [Related]
19. [Determination of plasma D-dimer in patients with pregnancy induced hypertension].
Zhou H; Chen R; Liu X
Zhonghua Fu Chan Ke Za Zhi; 1997 Jun; 32(6):347-9. PubMed ID: 9596914
[TBL] [Abstract][Full Text] [Related]
20. Are haemostatic and fibrinolytic parameters predictors of preeclampsia in pregnancy-associated hypertension?
Caron C; Goudemand J; Marey A; Beague D; Ducroux G; Drouvin F
Thromb Haemost; 1991 Oct; 66(4):410-4. PubMed ID: 1796389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
